lamin b1 antibody, Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results

Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results

Focal nodular hyperplasia (FNH) is a polyclonal tumour-like hepatic lesion characterised by parenchymal nodules, connective tissue septa without interlobular bile ducts, pronounced ductular reaction and inflammation. It may represent a response to local arterial hyperperfusion and hyperoxygenation resulting in oxidative stress. We aimed at obtaining closer insight into the pathogenesis of FNH with its characteristic…

Read More

Butein exhibits anti-tumor effect through intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in the human papillary thyroid cancer cell line

Epithelial-mesenchymal transition (EMT) and most cancers stem cells (CSCs) play a vital function in metastasis of papillary thyroid most cancers (PTC). Additional mesenchymal marker vimentin is linked with metastasis and most cancers stem cell technology. Therefore, inhibition of EMT and efficient elimination of CSCs gives a novel goal for the event of recent therapeutic brokers.…

Read More
LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma

LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma

Uveal melanoma (UM) is a uncommon ocular malignancy which originates within the uveal tract, and infrequently provides rise to metastases. Potential targets for immune checkpoint inhibition are lymphocyte-activation gene 3 (LAG3) and its ligands. We got down to analyse the distribution of those molecules in UM. The expression of mRNA was decided utilizing an Illumina…

Read More